Your NP Thyroid Dose Needs to Be Reduced
You are biochemically overreplaced with thyroid hormone and should decrease your total daily dose by 15-30 mg. Your suppressed TSH of 0.15 µIU/mL indicates excessive thyroid hormone replacement, which carries significant cardiovascular and skeletal risks that outweigh any symptomatic benefits 1, 2.
Why This Matters
Your current regimen (135 mg total daily) has driven your TSH well below the normal range (typically 0.4-4.12 mIU/L). This degree of suppression constitutes overtreatment, which guidelines explicitly warn against due to:
- Cardiovascular complications: Atrial fibrillation risk, particularly concerning if you're older 1
- Skeletal effects: Accelerated bone loss in postmenopausal women 1
- Affective disturbances: Mood and anxiety symptoms 1
The FDA labeling for NP Thyroid confirms that maintenance dosages of 60-120 mg/day typically result in normal TSH and thyroid hormone levels 2. You're currently taking 135 mg, which exceeds the typical maintenance range.
Specific Dose Adjustment Algorithm
Reduce your dose by 15 mg immediately (from 135 mg to 120 mg total daily):
- Take only the 120 mg tablet
- Discontinue the additional 15 mg tablet
Recheck labs in 4-8 weeks 1:
- TSH should be the primary therapeutic endpoint
- Target TSH: 0.4-4.0 mIU/L (ideally 1.0-2.5 mIU/L) 1
- Free T4 should normalize alongside TSH
If TSH remains suppressed (<0.4) after 4-8 weeks:
- Reduce by another 15 mg (to 105 mg total daily)
- Recheck in another 4-8 weeks
If TSH normalizes (0.4-4.0):
- Continue that dose
- Recheck at 6 months, then annually 1
Important Caveats
Do not ignore a suppressed TSH even if you feel well symptomatically. The evidence is clear that subclinical hyperthyroidism (suppressed TSH with normal free T4) causes harm over time, particularly cardiovascular and bone complications 1. Your subjective sense of wellness does not protect against these objective risks.
The T3 component in desiccated thyroid extract (like NP Thyroid) makes dose adjustments particularly important. DTE contains a 4:1 ratio of T4:T3, meaning your current dose delivers approximately 11+ mcg of T3 daily 3. This higher T3 content can more readily cause TSH suppression compared to levothyroxine monotherapy.
Age and cardiovascular status matter: If you're over 50-60 years or have any cardiac history, the risks of overtreatment are magnified 1. Even modest TSH suppression increases atrial fibrillation risk in older adults.
Monitoring Strategy
After dose reduction, assess:
- TSH as primary endpoint - must normalize to 0.4-4.0 mIU/L 1
- Free T4 - should be mid-normal range
- Total T3 - may be lower-normal or mildly low, which is acceptable 1
- Symptoms - fatigue, palpitations, tremor, heat intolerance
- Heart rate and rhythm - particularly if you're older
Do not chase a "perfect" T3 level. Guidelines emphasize that T3 levels may remain in the lower reference range even with adequate replacement, and this does not indicate undertreatment if TSH is normalized 1.
What If You Feel Worse After Reduction?
Some patients report persistent symptoms despite normalized TSH on any thyroid preparation. However, biochemical overtreatment must be corrected first before attributing symptoms to inadequate replacement 1. The evidence shows that 20% of treated patients are overtreated, and this carries definite harm 1.
If symptoms persist after achieving a normal TSH (0.4-4.0), then consider:
- Compliance and absorption issues
- Timing of medication (take on empty stomach, 30-60 minutes before food)
- Interfering medications or supplements (calcium, iron, PPIs, biotin) 1, 2
- Comorbid conditions contributing to symptoms
The current evidence does not support maintaining a suppressed TSH to achieve symptomatic relief in primary hypothyroidism 1, 4.